NovaBay Pharmaceuticals News

NovaBay Pharmaceuticals | 8-K: Current report

Nov 22 16:31 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Nov 15 08:13 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Nov 13 17:18 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Nov 12 16:58 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Nov 12 09:24 ET

NovaBay Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)

Nov 8 17:35 ET

NovaBay Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7 16:20 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Nov 6 17:02 ET

NovaBay Pharmaceuticals | 8-K: Current report

Nov 6 16:48 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Oct 29 08:23 ET

NovaBay Pharmaceuticals | 8-K: Current report

Oct 29 08:18 ET

NovaBay Pharmaceuticals | 8-K: Current report

Oct 16 16:28 ET

NovaBay Pharmaceuticals | DEFM14A: Definitive proxy statement relating to merger or acquisition

Oct 16 16:23 ET

NovaBay Pharmaceuticals | PREM14A: Preliminary proxy statements relating to merger or acquisition

Sep 25 17:20 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Sep 20 08:12 ET

NovaBay Pharmaceuticals | 8-K: Current report

Sep 20 08:12 ET

NovaBay Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 13 16:15 ET

NovaBay Pharmaceuticals | 8-K: Current report

Jul 29 16:30 ET

NovaBay Pharmaceuticals | 424B4: Prospectus

Jul 29 12:39 ET

NovaBay Pharmaceuticals | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement

Jul 26 17:24 ET